Abstract
To perform a burden of the disease study that quantifies direct and indirect medical costs in pediatric patients under 2 years of age diagnosed with a Respiratory Syncytial Virus infection (RSV) and risk factors from the perspective of Mexico’s public health institutions.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
